#Biomanufacturing / Pharmaceutical Services #Industrial Biotech
- Rare diseases
- Gene therapy
- Cell therapy
- Tissue replacement
- GMPs
- Contract Manufacturing
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.
Discover >Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.
Discover >Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Discover >Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.
Discover >#Biomanufacturing / Pharmaceutical Services #Industrial Biotech
Yposkesi, an SK pharmteco Company, is the first French company to develop and manufacture gene and cell therapy products for rare diseases.
BACKGROUND
Created in November 2016 by AFM-Telethon and the SPI fund managed by Bpifrance, this new company aims to make gene and cell therapies available to patients at a fair and controlled price, in accordance with the commitment made by its founders.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Activities:
CUSTOMER REFERENCES /COLLABORATIONS / HIGHLIGHTS
Yposkesi is certified as a pharmaceutical establishment (medicinal product for humanuse) by ANSM, the French national agency for health product safety.
The strategy of Yposkesi is focused on extending production capacities through planned investments.
145 Staff members
Strengths
– Biggest European Project for the production of gene and cell therapies.
– Broad epertise in the production process developmentand the associated control methods.
Innovation Assets
10% of Yposkesi human resources dedicated to innovation and development of new technologies.
In same field